Navidea Biopharma (NAVB) Reports In-Line Q4 Loss of 8c/Share
Tweet Send to a Friend
Navidea Biopharmaceuticals (NYSE: NAVB) reported Q4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
